While Wegovy and Zepbound added non-weight-loss indications, this second payer, instead, moved to outright rejecting claims between 70% and 80% of the time
At NFT concentrations 0.5 was observed in a comparison of gene expression profiles of PHH and HepG2 when exposed to different NFT concentrations (Suppl
Without the need for injection training or in-office administration, providers can shift their focus toward higher-value care activitiessuch as metabolic assessments, lifestyle counseling, progress tracking, and long-term outcome monitoring
Medicare may cover certain bariatric surgeries
Regulatory enforcement around compounded GLP-1s has been a moving target, and new branded entrants tend to increase scrutiny, not decrease it